Gene: ZNF226
Official Full Name: zinc finger protein 226provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34496 | ZNF226 Knockout cell line (HeLa) | Human | ZNF226 | 1:3~1:6 | Negative | Online Inquiry |
KO34497 | ZNF226 Knockout cell line (HCT 116) | Human | ZNF226 | 1:2~1:4 | Negative | Online Inquiry |
KO34498 | ZNF226 Knockout cell line (HEK293) | Human | ZNF226 | 1:3~1:6 | Negative | Online Inquiry |
KO34499 | ZNF226 Knockout cell line (A549) | Human | ZNF226 | 1:3~1:4 | Negative | Online Inquiry |
ZNF226 Gene Knockout Cell Lines are genetically modified cell lines that have been engineered to disrupt the expression of the ZNF226 gene, a member of the zinc finger transcription factor family known for its roles in gene regulation and cellular differentiation. These cell lines serve as vital tools for studying the physiological and pathophysiological roles of ZNF226, providing insights into its function in various biological processes such as cell growth, apoptosis, and development.
The knockout mechanism utilized involves the application of CRISPR-Cas9 technology, which allows for precise editing of the genome. Through targeted double-strand breaks and subsequent repair process failures, ZNF226 is effectively inactivated, leading to a loss of its function. Researchers can utilize these cell lines to dissect the downstream signaling pathways affected by the loss of ZNF226, thereby elucidating its role in various cellular contexts.
The scientific importance of ZNF226 Gene Knockout Cell Lines extends to both fundamental research and potential clinical applications. They are particularly valuable in cancer research, where aberrant regulation of transcription factors often contributes to tumorigenesis. Additionally, these knockout cell lines can be applied in drug discovery, enabling the identification of novel therapeutic targets and the validation of potential treatments based on the functional consequences of ZNF226 loss.
Compared to conventional gene silencing methods such as RNA interference, ZNF226 Gene Knockout Cell Lines offer several advantages: they provide stable, long-term disruption of gene expression, which results in a more predictable phenotype. Moreover, they facilitate comprehensive studies that can yield insights not achievable through temporary knockdown strategies.
For researchers and clinicians, ZNF226 Gene Knockout Cell Lines represent a cutting-edge resource that enables a deeper understanding of gene function in health and disease. Their utilization can lead to breakthroughs in identifying therapeutic targets and advancing personalized medicine approaches.
Our company prides itself on its commitment to providing high-quality, reliable biological products, backed by rigorous scientific validation and superb customer support. We understand the critical nature of your research endeavors and are dedicated to supporting your groundbreaking work with innovative solutions like the ZNF226 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.